Antibody Treatment and Osteoporosis: Clinical Perspective

Springer Series in Biomaterials Science and Engineering - Innovative Bioceramics in Translational Medicine II ◽

10.1007/978-981-16-7439-6_6 ◽

2022 ◽

pp. 111-126

Author(s):

Giacomina Brunetti ◽

Sara Todisco ◽

Maria Grano

Keyword(s):

Clinical Perspective ◽

Antibody Treatment

Download Full-text

Review of The Clinical Perspective in Fieldwork: Qualitative Research Methods, Vol. 5.

Contemporary Psychology ◽

10.1037/025669 ◽

1988 ◽

Vol 33 (4) ◽

pp. 376-376

Author(s):

No authorship indicated

Keyword(s):

Qualitative Research ◽

Research Methods ◽

Qualitative Research Methods ◽

Clinical Perspective

Download Full-text

Maintenance of behavior change in cadiorespiratory risk reduction: A clinical perspective from the Ornish Program for reversing coronary heart disease.

Health Psychology ◽

10.1037/0278-6133.19.suppl1.70 ◽

2000 ◽

Vol 19 (1, Suppl) ◽

pp. 70-75 ◽

Author(s):

James H. Billings

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Behavior Change ◽

Risk Reduction ◽

Clinical Perspective

Download Full-text

Gaining Clinical Perspective on Self-Injury

PsycCRITIQUES ◽

10.1037/a0041090 ◽

2017 ◽

Vol 62 (47) ◽

Author(s):

Andrew Nocita

Keyword(s):

Clinical Perspective ◽

Download Full-text

Review of The psychology of existence: An integrative, clinical perspective.

Psychotherapy ◽

10.1037/h0092408 ◽

1998 ◽

Vol 35 (3) ◽

pp. 431-431

Author(s):

Pauline Rose Clance

Keyword(s):

Clinical Perspective

Download Full-text

Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterized by interferon-gamma-expressing Th1 and IL-17/IL-22-expressing Th17 cell infiltrates and respond to anti-IL-12/IL-23 antibody treatment

Zeitschrift für Gastroenterologie ◽

10.1055/s-0032-1324133 ◽

2012 ◽

Vol 50 (08) ◽

Author(s):

C Tillack ◽

L Ehmann ◽

S Koglin ◽

J Schauber ◽

A Wollenberg ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Interferon Gamma ◽

Bowel Disease ◽

Th17 Cell ◽

Skin Lesions ◽

Antibody Treatment ◽

Inflammatory Bowel

Download Full-text

Decision letter for "Sclerostin‐Neutralizing Antibody Treatment Rescues Negative Effects of Rosiglitazone on Mouse Bone Parameters"

10.1002/jbmr.4170/v1/decision1 ◽

2020 ◽

Keyword(s):

Negative Effects ◽

Antibody Treatment ◽

Bone Parameters

Download Full-text

Osteogenesis imperfecta and short stature: effect of sclerostin antibody treatment in oim/oim mice

Bone Abstracts ◽

10.1530/boneabs.2.p80 ◽

2013 ◽

Author(s):

Cardinal Mickael ◽

Nyssen-Behets Catherine ◽

Ominsky Mike ◽

Devogelaer Jean-Pierre ◽

H Manicourt Daniel

Keyword(s):

Osteogenesis Imperfecta ◽

Short Stature ◽

Antibody Treatment ◽

Sclerostin Antibody

Download Full-text

Misophonia and Affective Disorders: The Relationship and Clinical Perspective

10.26226/morressier.5885d712d462b8028d892321 ◽

2017 ◽

Author(s):

Mercede Erfanian Ghasab

Keyword(s):

Affective Disorders ◽

Clinical Perspective ◽

The Relationship

Download Full-text

Orphan designation: Humanised anti-IL-6 receptor monoclonal antibody, Treatment of neuromyelitis optica spectrum disorders

Case Medical Research ◽

10.31525/cmr-973984 ◽

2019 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Neuromyelitis Optica ◽

Neuromyelitis Optica Spectrum Disorders ◽

Antibody Treatment ◽

Orphan Designation ◽

Monoclonal Antibody Treatment ◽

Spectrum Disorders ◽

Receptor Monoclonal Antibody

Download Full-text

Faculty Opinions recommendation of Adult Brtl/+ mouse model of osteogenesis imperfecta demonstrates anabolic response to sclerostin antibody treatment with increased bone mass and strength.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718465259.793509203 ◽

2015 ◽

Author(s):

Joseph Shaker

Keyword(s):

Mouse Model ◽

Bone Mass ◽

Osteogenesis Imperfecta ◽

Antibody Treatment ◽

Anabolic Response ◽

Sclerostin Antibody

Download Full-text